Table 1.

Demographics – characteristics and baseline details

Patient demographics
Patients enrolled	20
Patients with $\ge$1 follow-up (patients [eyes])	19 [31]
Patients followed per protocol (patients [eyes])	18 [30]
Mean age (yr)	43.0
Sex, n (%)
Female	17 (89.5)
Male	2 (10.5)
Race, n (%)
Caucasian	16 (84.2)
Hispanic or Latin	2 (10.5)
South Asian	1 (5.3)
Patients with uveitis, n (%)	18 (94.7)
Uveitis diagnosis, n (%)
Anterior	2 (10.5)
Intermediate	3 (15.8)
Posterior	1 (5.3)
Panuveitis	12 (63.2)
Mean time with uveitis prior to the study (yr)	5.8$\pm$ 3.93
Mean time with active symptoms prior to the study (months)	2.0$\pm$ 2.31
Patients with idiopathic disease, n (%)	9 (47.4)
Patients with systemic association, n (%)	10 (52.7)
HLA-B27	3 (15.8)
Multiple sclerosis	2 (10.5)
Sarcoidosis	5 (26.3)
Patients on systemic anti-inflammatory medication, n (%)	8 (42.1)